Rare diseases
Investigational molecules
Locations
490 Arsenal Way, 02472-2988, United States
Tectonic Therapeutic Inc. focuses on clinical research in pulmonary hypertension linked to heart failure with preserved ejection fraction (HFpEF), with attention to haemodynamic impairment in patients affected by combined postcapillary and precapillary pulmonary hypertension and isolated postcapillary pulmonary hypertension.
The sponsor’s research interest centres on therapies intended to address elevated pulmonary vascular resistance and the clinical burden associated with HFpEF-related pulmonary vascular disease.
Tectonic Therapeutic Inc. runs clinical trials in conditions such as Pulmonary hypertension, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
AustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
